Skip to content

To Study The Effect Of Amalaki Siddha Ghee Tarpana In Dry Eye Disease

A Randomized Controlled Clinical Study Of Amalaki Siddha Ghrita Tarpana In Dry Eye Disease

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053782
Enrollment
42
Registered
2023-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa Health Condition 2: H049- Disorder of lacrimal system, unspecified

Interventions

None listed

Sponsors

Dr Krushna Mahakal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients suffering from mild to moderate Dry eye disease who are willing to participate will be selected

Exclusion criteria

Exclusion criteria: patient with severe dry eye disease or any occular surface pathology or congenital anamolies of eye or one eyed patient or patient with eye lid disease or noncooperative patient

Design outcomes

Primary

MeasureTime frame
TFBUT test value to increase by 2-3 secs. Schirmer-I test value to increase by 1-2 units (1mm-2mm)Timepoint: 7 days tarpana will be given,follow up will be on (7th and 14th day)

Secondary

MeasureTime frame
Reduction in the symptoms of Dryness, Eye fatigue, Redness, Burning sensation, Itching, Headache as compared to the standard drug mentioned in the subjective criteriaTimepoint: 7 days tarpana will be given,follow up will be on (7th and 14th day)

Countries

India

Contacts

Public ContactDr Krushna Mahakal

Bharati Vidyapeeth (Deemed to be university), College of Ayurved and hospital

drsantoshmulik@gmail.com9823491389

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026